Loading
IARC estimates 3,575 new cancer cases and 2,264 cancer deaths in Republic of the Congo in 2024; the commonest new cancers are breast, cervix uteri and prostate. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 755 | 33.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 589 | 30.2 | Cervical cancer |
| Prostate | 461 | 35.8 | Prostate cancer |
| Liver and intrahepatic bile ducts | 352 | 8.7 | Hepatocellular carcinoma |
| Colorectum | 321 | 8.6 | Colorectal cancer |
| Leukaemia | 132 | 2.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Stomach | 131 | 3.5 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 62 | 1.8 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Pancreas | 59 | 1.7 | Pancreatic ductal adenocarcinoma |
| Multiple myeloma | 50 | 1.4 | Multiple myeloma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 384 | 19.8 | Cervical cancer |
| Breast | 375 | 17.2 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 313 | 8.0 | Hepatocellular carcinoma |
| Prostate | 292 | 22.6 | Prostate cancer |
| Colorectum | 187 | 5.1 | Colorectal cancer |
| Stomach | 98 | 2.7 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 91 | 2.0 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Pancreas | 59 | 1.7 | Pancreatic ductal adenocarcinoma |
| Trachea, bronchus and lung | 56 | 1.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Multiple myeloma | 37 | 1.1 | Multiple myeloma |
No trial record in OnCo lists a site in Republic of the Congo. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Republic of the Congo.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Republic of the Congo is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Republic of the Congo is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.